搜索页_+ipilimumab

设为首页

收藏本站

网站地图 | English | 公务邮箱

About the library

Background
History
Leadership
Organization

Readers' Guide

Opening Hours
Collections
Help Via Email

Publications

Electronic Information Resources

外文资源

Elsevier电子期刊(215)

在“Elsevier电子期刊”中，命中：215条，耗时：小于0.01 秒

在所有数据库中总计命中：215条

1.Immune-mediated Disease in Ipilimumab Immunotherapy of Melanoma with FDG PET-CT

作者：Jason W. Wachsmann ; MD^a ; ^{Jason.Wachsmann@UTSouthwestern.edu} ; Ramapriya Ganti ; MD ; PhD^a ; Fangyu Peng ; MD ; PhD^a ; ^b

关键词：FDG ; PET-CT ; melanoma ; ipilimumab ; immune-related adverse events

刊名：Academic Radiology

出版年：2017

2.Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study

作者：Dr Matthew D Hellmann ; MD^a ; ^{hellmanm@mskcc.org} ; Prof Naiyer A Rizvi ; MD^a ; Jonathan W Goldman ; MD^b ; Scott N Gettinger ; MD^c ; Hossein Borghaei ; DO^d ; Julie R Brahmer ; MD^e ; Prof Neal E Ready ; MD^f ; David E Gerber ; MD^g ; Laura Q Chow ; MD^h ; Rosalyn A Juergens ; MDⁱ ; Prof Frances A Shepherd ; MD^j ; Scott A Laurie ; MD^k ; William J Geese ; PhD^l ; Shruti Agrawal ; PhD^l ; Tina C Young ; MS^l ; Xuemei Li ; MD^l ; Prof Scott J Antonia ; MD^m

刊名：The Lancet Oncology

出版年：2017

3.Copy number variation analysis and methylome profiling of a GNAQ-mutant primary meningeal melanocytic tumor and its liver metastasis

作者：Heidi V.N. Kü ; sters-Vandevelde^a ; ¹ ; ^{h.kusters@cwz.nl} ; Vibeke Kruse^b ; ¹ ; ^{Vibeke.Kruse@uzgent.be} ; Tom Van Maerken^c ; ^{Tom.VanMaerken@ugent.be} ; Tom Boterberg^d ; ^{Tom.Boterberg@uzgent.be} ; Rolph Pfundt^e ; ^{Rolph.Pfundt@radboudumc.nl} ; David Creytens^f ; ^{David.Creytens@uzgent.be} ; Caroline Van den Broecke^f ; ^{cvdbroec@me.com} ; Trudi C. Machielsen^e ; ^{Trudi.Machielsen@radboudumc.nl} ; Christian Koelsche^g ; ^{Christian.Koelsche@med.uni-heidelberg.de} ; Andreas von Deimling^g ; ^{Andreas.vonDeimling@med.uni-heidelberg.de} ; Benno Kü ; sters^h ; ⁱ ; ^{Benno.Kusters@radboudumc.nl} ; Patricia J.T.A. Groenen^h ; ^{Patricia.Groenen@radboudumc.nl} ; Pieter Wesseling^j ; ^k ; ^{p.wesseling@vumc.nl} ; Willeke A.M. Blokx^h ; ^{Willeke.Blokx@radboudumc.nl}

关键词：Meningeal melanocytic tumor ; Meningeal melanoma ; Liver metastasis ; GNAQ ; Copy number variations ; Methylation ; Ipilimumab

刊名：Experimental and Molecular Pathology

出版年：2017

4.Autoimmune Cardiotoxicity of Cancer Immunotherapy

作者：Feixiong Cheng¹ ; ² ; ^{fxcheng1985@gmail.com} ; Joseph Loscalzo³ ; ^{jloscalzo@partners.org}

关键词：cardio-oncology ; ipilimumab ; nivolumab ; immune checkpoint ; immunotherapy.

刊名：Trends in Immunology

出版年：2017

5.Combined low-dose ipilimumab and pembrolizumab after sequential ipilimumab and pembrolizumab failure in advanced melanoma

作者：Michael C. Kirchberger^a ; Axel Hauschild^b ; Gerold Schuler^a ; Lucie Heinzerling^a ; ^{Lucie.Heinzerling@uk-erlangen.de" class="auth_mail" title="E-mail the corresponding author}

关键词：Ipilimumab ; Pembrolizumab ; Anti-PD-1 ; Melanoma ; Combined immunotherapy

刊名：European Journal of Cancer

出版年：2016

6.Dutch Melanoma Treatment Registry: Quality assurance in the care of patients with metastatic melanoma in the Netherlands

作者：Anouk Jochems^a ; ¹ ; Maartje G. Schouwenburg^a ; ¹ ; Brenda Leeneman^b ; Margreet G. Franken^b ; Alfons J.M. van den Eertwegh^c ; John B.A.G. Haanen^d ; Hans Gelderblom^a ; Carin A. Uyl-de Groot^b ; Maureen J.B. Aarts^e ; Franchette W.P.J. van den Berkmortel^f ; Willeke A.M. Blokx^g ; Mathilde C. Cardous-Ubbink^h ; Gerard Groenewegenⁱ ; Jan Willem B. de Groot^j ; Geke A.P. Hospers^k ; Ellen Kapiteijn^a ; Rutger H. Koornstra^l ; Wim H. Kruit^m ; Marieke W. Louwman^h ; Djura Piersmaⁿ ; Rozemarijn S. van Rijn^o ; Albert J. ten Tije^p ; Gerard Vreugdenhil^q ; Michel W.J.M. Wouters^r ; Jacobus J.M. van der Hoeven^a ; ^{J.J.M.van_der_Hoeven@lumc.nl}

关键词：Quality assurance ; Metastatic melanoma ; Checkpoint inhibitors ; MAP kinase inhibitors ; Population-based ; Registry ; Ipilimumab

刊名：European Journal of Cancer

出版年：2017

7.Adjuvant ipilimumab in stage III melanoma: New landscape, new questions

作者：Alexander M.M. Eggermont^a ; ^b ; ^{alexander.eggermont@gustaveroussy.fr}

关键词：Melanoma ; Ipilimumab ; Adjuvant therapy ; Randomised trials ; Survival

刊名：European Journal of Cancer

出版年：2016

8.Immune checkpoint inhibitors for nonsmall cell lung cancer treatment

作者：Yuh-Min Chen^a ; ^b ; ^c ; ^{ymchen@vghtpe.gov.tw}

关键词：adenocarcinoma ; checkpoint inhibitor ; immunotherapy ; lung cancer ; lymphocytes

刊名：Journal of the Chinese Medical Association

出版年：2017

9.Stability of ipilimumab in its original vial after opening allows its use for at least 4 weeks and facilitates pooling of residues

作者：Pascale Bardo-Brouard^a ; ^{pascale.bardo@aphp.fr" class="auth_mail" title="E-mail the corresponding author} ; ^{pascale.bardo@gmail.com" class="auth_mail" title="E-mail the corresponding author} ; Victoire Vieillard^a ; Tala Shekarian^b ; Auré ; lien Marabelle^b ; ^c ; Alain Astier^a ; Muriel Paul^a

关键词：Ipilimumab ; Monoclonal antibody ; Stability ; Immunotherapy

刊名：European Journal of Cancer

出版年：2016

10.Toxicity of definitive and post-operative radiation following ipilimumab in non-small cell lung cancer

作者：Matthew J. Boyer^a ; ^{mjb14@dm.duke.edu" class="auth_mail" title="E-mail the corresponding author} ; Lin Gu^b ; Xiaofei Wang^b ; Chris R. Kelsey^a ; David S. Yoo^a ; Mark W. Onaitis^c ; Frank R. Dunphy^d ; Jeffrey Crawford^d ; Neal E. Ready^d ; Joseph K. Salama^a

关键词：Non-small cell lung cancer ; Ipilimumab ; Radiation ; Toxicity

刊名：Lung Cancer

出版年：2016

按检索点细分(215)

题名(111)

关键词(55)

文摘(127)

按出版年细分(215)

2027年及以后(20)

2017年(6)

2016年(73)

2015年(26)

2013年(29)

2012年(31)

2011年(6)

2010年(7)

2009年(13)

2007年(3)

2000年及以前(1)